63 related articles for article (PubMed ID: 11176393)
1. Testicular function among testicular cancer survivors treated with cisplatin-based chemotherapy.
Namekawa T; Imamoto T; Kato M; Sazuka T; Fuse M; Sakamoto S; Kawamura K; Ichikawa T
Reprod Med Biol; 2016 Jul; 15(3):175-181. PubMed ID: 29259434
[TBL] [Abstract][Full Text] [Related]
2. Comparative study of the fertility potential of men with only one testis.
Ferreira U; Netto Júnior NR; Esteves SC; Rivero MA; Schirren C
Scand J Urol Nephrol; 1991; 25(4):255-9. PubMed ID: 1685802
[TBL] [Abstract][Full Text] [Related]
3. Systemic therapy for primary and extragonadal germ cell tumors: prognosis and nuances of treatment.
Siddiqui BA; Zhang M; Pisters LL; Tu SM
Transl Androl Urol; 2020 Jan; 9(Suppl 1):S56-S65. PubMed ID: 32055486
[TBL] [Abstract][Full Text] [Related]
4. Long-Term Follow Up of the Erectile Function of Testicular Cancer Survivors.
Pallotti F; Petrozzi A; Cargnelutti F; Radicioni AF; Lenzi A; Paoli D; Lombardo F
Front Endocrinol (Lausanne); 2019; 10():196. PubMed ID: 31001201
[TBL] [Abstract][Full Text] [Related]
5. Anticancer chemotherapeutic agents and testicular dysfunction.
Yamaguchi K; Fujisawa M
Reprod Med Biol; 2011 Jun; 10(2):81-87. PubMed ID: 29699084
[TBL] [Abstract][Full Text] [Related]
6. A Review in Management of Testicular Cancer: Single Center Review.
Hameed A; White B; Chinegwundoh F; Thwaini A; Pahuja A
World J Oncol; 2011 Jun; 2(3):94-101. PubMed ID: 29147233
[TBL] [Abstract][Full Text] [Related]
7. Process and Pitfalls of Sperm Cryopreservation.
Rozati H; Handley T; Jayasena CN
J Clin Med; 2017 Sep; 6(9):. PubMed ID: 28925939
[TBL] [Abstract][Full Text] [Related]
8. Evolving patterns of care in the management of stage I non-seminomatous germ cell tumors: data from the California Cancer Registry.
Yap SA; Yuh LM; Evans CP; Dall'Era MA; Wagenaar RM; Cress R; Lara PN
World J Urol; 2017 Feb; 35(2):277-283. PubMed ID: 27306686
[TBL] [Abstract][Full Text] [Related]
9. Sexual functioning of testicular cancer survivors and their partners - A review of literature.
Jankowska M
Rep Pract Oncol Radiother; 2011 Dec; 17(1):54-62. PubMed ID: 24376997
[TBL] [Abstract][Full Text] [Related]
10. Sexual functioning among testicular cancer survivors: a case-control study in the U.S.
Kim C; McGlynn KA; McCorkle R; Li Y; Erickson RL; Ma S; Niebuhr DW; Zhang G; Zhang Y; Bai Y; Dai L; Graubard BI; Zheng T; Aschebrook-Kilfoy B; Barry KH; Zhang Y
J Psychosom Res; 2012 Jul; 73(1):68-73. PubMed ID: 22691563
[TBL] [Abstract][Full Text] [Related]
11. Risk-adapted management for patients with clinical stage I non-seminomatous germ cell tumour of the testis.
Guney S; Guney N; Sonmez NC; Ergenekon E
Med Oncol; 2009; 26(2):136-42. PubMed ID: 18821067
[TBL] [Abstract][Full Text] [Related]
12. Subjective quality of life and sexual functioning after germ-cell tumour therapy.
Fegg MJ; Gerl A; Vollmer TC; Gruber U; Jost C; Meiler S; Hiddemann W
Br J Cancer; 2003 Dec; 89(12):2202-6. PubMed ID: 14676795
[TBL] [Abstract][Full Text] [Related]
13. Infertility rates following POMB/ACE chemotherapy for male and female germ cell tumours - a retrospective long-term follow-up study.
Gaffan J; Holden L; Newlands ES; Short D; Fuller S; Begent RH; Rustin GJ; Seckl MJ
Br J Cancer; 2003 Nov; 89(10):1849-54. PubMed ID: 14612891
[TBL] [Abstract][Full Text] [Related]
14. Fertility and sexual function following orchiectomy and 2 cycles of chemotherapy for stage I high risk nonseminomatous germ cell cancer.
Böhlen D; Burkhard FC; Mills R; Sonntag RW; Studer UE
J Urol; 2001 Feb; 165(2):441-4. PubMed ID: 11176393
[TBL] [Abstract][Full Text] [Related]
15. Long-term followup results of 1 cycle of adjuvant bleomycin, etoposide and cisplatin chemotherapy for high risk clinical stage I nonseminomatous germ cell tumors of the testis.
Westermann DH; Schefer H; Thalmann GN; Karamitopoulou-Diamantis E; Fey MF; Studer UE
J Urol; 2008 Jan; 179(1):163-6. PubMed ID: 18001800
[TBL] [Abstract][Full Text] [Related]
16. Long-term results following adjuvant chemotherapy in patients with clinical stage I testicular nonseminomatous malignant germ cell tumors with high risk factors.
Böhlen D; Borner M; Sonntag RW; Fey MF; Studer UE
J Urol; 1999 Apr; 161(4):1148-52. PubMed ID: 10081858
[TBL] [Abstract][Full Text] [Related]
17. Testicular function in poor-risk nonseminomatous germ cell tumors treated with methotrexate, paclitaxel, ifosfamide, and cisplatin combination chemotherapy.
Pectasides D; Pectasides E; Papaxoinis G; Skondra M; Gerostathou M; Karageorgopoulou S; Kamposioras C; Tountas N; Koumarianou A; Psyrri A; Macheras A; Economopoulos T
J Androl; 2009; 30(3):280-6. PubMed ID: 19136393
[TBL] [Abstract][Full Text] [Related]
18. The value of prognostic factors in the management of stage I nonseminomatous germ cell testicular tumors (NSGCTT).
Ondrus D; Goncalves F; Kausitz J; Mat'oska J; Belan V
Neoplasma; 1996; 43(3):195-7. PubMed ID: 8841507
[TBL] [Abstract][Full Text] [Related]
19. Gonadal function in men with testicular cancer.
Petersen PM; Giwercman A; Skakkebaek NE; Rørth M
Semin Oncol; 1998 Apr; 25(2):224-33. PubMed ID: 9562456
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
